Elite Pharmaceuticals Inc (ELTP)

[Cake Eater]

Agreed.

While uplisting from the OTC markets to a major exchange like Nasdaq offers increased visibility, liquidity, and access to institutional investors, there are several reasons why Elite may choose to remain on the OTC markets.
OTC markets have significantly lower listing and ongoing compliance costs compared to Nasdaq, which requires substantial fees and resources to meet and maintain stricter financial, governance, and reporting standards.
OTC-listed companies face less stringent regulatory and disclosure requirements, reducing the administrative and legal overhead associated with public company compliance on a national exchange.
Companies on the OTC markets have more flexibility in their operations and financial reporting, as they are not subject to the same level of scrutiny and governance as Nasdaq-listed firms.
Uplisting is not guaranteed to result in higher share prices or increased liquidity, and the process itself can be costly and time-consuming.
Companies that uplist before they are operationally or financially ready may struggle to meet ongoing requirements, risking delisting or reputational harm.